SCHEMBL3528481

SCHEMBL3528481

CC(C)c1ccc2sc3ccccc3c(=O)c2c1[S+]([O-])c1c(C(C)C)ccc2sc3ccccc3c(=O)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
HPGD P15428 1/20 0.46
CYP2C19 P33261 1/20 0.46
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
ALDH1A1 P00352 4/20 0.40
POLB P06746 4/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
GAA P10253 2/20 0.40
KDM4E B2RXH2 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
NPSR1 Q6W5P4 2/20 0.37
BLM P54132 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27980566 0.80 MAPT (0.54) MAPTNPC1RAB9ACYP1A2CYP3A4
SCHEMBL156858 0.80 MAPT (0.50) MAPTNPC1RAB9ACYP1A2CYP3A4
Phosphine SCHEMBL28097474 0.79 MAPT (0.49) MAPTNPC1RAB9ACYP1A2CYP3A4
SCHEMBL3208280 0.79 MAOA (0.52) MAPTNPC1RAB9ACYP1A2CYP3A4
SCHEMBL20448784 0.79 MAPT (0.49) MAPTNPC1RAB9ACYP1A2CYP3A4
SCHEMBL4634508 0.79 KDM4E (0.49) MAPTNPC1RAB9ACYP1A2CYP3A4
SCHEMBL29675381 0.78 MAPT (0.50) MAPTNPC1RAB9ACYP1A2CYP3A4
SCHEMBL52045 0.78 MAPT (0.50) MAPTNPC1RAB9ACYP1A2CYP3A4
SCHEMBL29359906 0.78 MAPT (0.50) MAPTNPC1RAB9ACYP1A2CYP3A4
SCHEMBL27760689 0.78 MAPT (0.50) MAPTNPC1RAB9ACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7671081-B2 Multifunctional cationic photoinitiators, their preparation and use SUN CHEMICAL CORPORATION (US) 2010-03-02 US disclosed
US-7598401-B2 Multifunctional cationic photoinitiators, their preparation and use SUN CHEMICAL CORPORATION (US) 2009-10-06 US disclosed
US-20090023829-A1 MULTIFUNCTIONAL CATIONIC PHOTOINITIATORS, THEIR PREPARATION AND USE SUN CHEMICAL CORPORATION (US) 2009-01-22 US disclosed
EP-1480967-B8 FUSED RING COMPOUNDS, AND THEIR USE AS CATIONIC PHOTOINITIATORS SUN CHEMICAL CORP (US) 2008-10-01 EP disclosed
EP-1480967-B1 FUSED RING COMPOUNDS, AND THEIR USE AS CATIONIC PHOTOINITIATORS SUN CHEMICAL CORP (US) 2008-06-04 EP disclosed
US-20080081917-A1 MULTIFUNCTIONAL CATIONIC PHOTOINITIATORS, THEIR PREPARATION AND USE SUN CHEMICAL CORPORATION (US) 2008-04-03 US disclosed
US-7294723-B2 Multifunctional cationic photoinitiators, their preparation and use SUN CHEMICAL CORPORATION (US) 2007-11-13 US disclosed
EP-1581513-B1 MULTIFUNCTIONAL CATIONIC PHOTOINITIATORS, THEIR PREPARATION AND USE SUN CHEMICAL CORP (US) 2007-02-14 EP disclosed
US-20060241200-A1 Multifunctional cationic photoinitiators, their preparation and use SUN CHEMICAL CORPORATION 2006-10-26 US disclosed
US-7101998-B2 Fused ring compounds, and their use as cationic photoinitiators SUN CHEMICAL CORPORATION (JP) 2006-09-05 US disclosed
EP-1581513-A1 MULTIFUNCTIONAL CATIONIC PHOTOINITIATORS, THEIR PREPARATION AND USE Sun Chemical Corporation (US) 2005-10-05 EP disclosed
US-20050176969-A1 Novel fused ring compounds, and their use as cationic photoinitiators SUN CHEMICAL CORPORATION 2005-08-11 US disclosed
EP-1480967-A1 NOVEL FUSED RING COMPOUNDS, AND THEIR USE AS CATIONIC PHOTOINITIATORS SUN CHEMICAL CORPORATION (US) 2004-12-01 EP disclosed
WO-2004055000-A1 MULTIFUNCTIONAL CATIONIC PHOTOINITIATORS, THEIR PREPARATION AND USE SUN CHEMICAL CORPORATION (US) 2004-07-01 WO disclosed
WO-2003072567-A1 NOVEL FUSED RING COMPOUNDS, AND THEIR USE AS CATIONIC PHOTOINITIATORS SUN CHEMICAL CORPORATION (US) 2003-09-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060241200-A1 Multifunctional cationic photoinitiators, their preparation and use DOT1L, YWHAH, H1-10 MAPT 4233/4885NPC1 4432/4885RAB9A 128/4885
US-20050176969-A1 Novel fused ring compounds, and their use as cationic photoinitiators SUV39H2, DOT1L, H1-10 MAPT 2269/4885NPC1 3864/4885RAB9A 28/4885
US-20080081917-A1 MULTIFUNCTIONAL CATIONIC PHOTOINITIATORS, THEIR PREPARATION AND USE CNKSR1, YWHAZ, YWHAH MAPT 4195/4885NPC1 4374/4885RAB9A 102/4885
US-20090023829-A1 MULTIFUNCTIONAL CATIONIC PHOTOINITIATORS, THEIR PREPARATION AND USE YWHAZ, PYM1, CNKSR1 MAPT 4200/4885NPC1 4450/4885RAB9A 177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.